Get informed when a big investor buys or sells
+ FollowOvervalued by 124.9% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $4.10 Million |
|---|---|
| Enterprise Value | $4.17 Million |
| Earnings per Share | $-0.02 |
| Beta | 2.26 |
| Outstanding Shares | 40,976,000 |
| P/E Ratio | -35 |
|---|---|
| PEG | -36.11 |
| Price to Sales | - |
| Price to Book Ratio | -0.1 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -45.13 |
| Enterprise Value to Net Income | -51 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | -1.52 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Cycclone Inc., operating with its subsidiaries, specializes in the development, promotion, and distribution of bacteria-derived products. These offerings primarily function as beneficial additives for both agricultural crops and animal f...